| Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches MO Idris, AA Yekeen, OS Alakanse, OA Durojaye Journal of Biomolecular Structure and Dynamics 39 (15), 5638-5656, 2021 | 83 | 2021 |
| CHAPERONg: A tool for automated GROMACS-based molecular dynamics simulations and trajectory analyses AA Yekeen, OA Durojaye, MO Idris, HF Muritala, RO Arise Computational and Structural Biotechnology Journal 21, 4849-4858, 2023 | 23 | 2023 |
| Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells S Du, X Song, Y Li, Y Cao, F Chu, OA Durojaye, Z Su, X Shi, J Wang, ... Scientific Reports 10 (1), 11273, 2020 | 22 | 2020 |
| A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans AS Odiba, OA Durojaye, IM Ezeonu, AC Mgbeahuruike, BC Nwanguma Infection and Drug Resistance, 3111-3133, 2022 | 13 | 2022 |
| MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference OA Durojaye, NO Okoro, AS Odiba, BC Nwanguma Scientific Reports 13 (1), 6972, 2023 | 9 | 2023 |
| Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein HO Uzoeto, JN Ajima, AV Arazu, GO Ibiang, S Cosmas, OA Durojaye Journal of Genetic Engineering and Biotechnology 20 (1), 10, 2022 | 9 | 2022 |
| Computer-aided molecular modeling and structural analysis of the human centromere protein–HIKM complex HO Uzoeto, S Cosmas, JN Ajima, AV Arazu, CM Didiugwu, DE Ekpo, ... Beni-Suef University Journal of Basic and Applied Sciences 11 (1), 101, 2022 | 8 | 2022 |
| Mad2 promotes Cyclin B2 recruitment to the kinetochore for guiding accurate mitotic checkpoint S Liu, X Yuan, P Gui, R Liu, O Durojaye, DL Hill, C Fu, X Yao, Z Dou, X Liu EMBO reports 23 (6), e54171, 2022 | 8 | 2022 |
| Identification of a potential mRNA‐based vaccine candidate against the SARS‐CoV‐2 spike glycoprotein: A reverse vaccinology approach OA Durojaye, DM Sedzro, MO Idris, AA Yekeen, AA Fadahunsi, ... ChemistrySelect 7 (7), e202103903, 2022 | 8 | 2022 |
| Evaluation of 6-Gingerol and its modified analogues as therapeutic candidates against Schistosoma mansoni phosphofructokinase OA Durojaye, BC Nwanguma, PE Joshua, JO Ogidigo, S Cosmas, ... VacciMonitor 28 (1), 38-47, 2019 | 8 | 2019 |
| An in-silico pharmacokinetics study on Cis-heptadeca-1, 9-Diene-4, 6-Diyne-3, 8-Diol: A nutraceutical compound with anticancer properties PT Okoli, VC Nzute, OA Durojaye, OH Chielo, QC Ajibo, SI Udo, SM Ezeh Asian Food Science Journal 7 (3), 1-7, 2019 | 7 | 2019 |
| Clinical diagnosis of disease states using enzymes and proteins N Evalde, PO James, O Onuorah, CC Ilo, D Okeowhor, S Cosmas, ... Asian Journal of Biochemistry, Genetics and Molecular Biology 1 (3), 1-6, 2019 | 7 | 2019 |
| Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study OA Durojaye, T Mushiana, HO Uzoeto, S Cosmas, VM Udowo, ... Egyptian Journal of Medical Human Genetics 21, 1-17, 2020 | 6 | 2020 |
| Csc01 shows promise as a potential inhibitor of the oncogenic G13D mutant of KRAS: an in silico approach OA Durojaye, U Ejaz, HO Uzoeto, AA Fadahunsi, AO Opabunmi, DE Ekpo, ... Amino Acids 55 (12), 1745-1764, 2023 | 5 | 2023 |
| Oral cavity infection by the SARS-CoV-2: emphasizing the essence of masking and peptide therapeutics GO Ibiang, J Malachi, MO Ibiang, DK Chukwudi, OA Durojaye Egyptian Journal of Medical Human Genetics 23, 1-7, 2022 | 4 | 2022 |
| Identifying Potential p53‐MDM2 Interaction Antagonists: An Integrated Approach of Pharmacophore‐Based Virtual Screening, Interaction Fingerprinting, MD Simulation and DFT Studies DM Sedzro, MO Idris, OA Durojaye, AA Yekeen, AA Fadahunsi, ... ChemistrySelect 7 (39), e202202380, 2022 | 4 | 2022 |
| Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders AS Odiba, NO Okoro, OA Durojaye, Y Wu Open Life Sciences 16 (1), 431-441, 2021 | 4 | 2021 |
| Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study JN Nwachukwu, OA Durojaye, UO Njoku, MM Tanze, N Christian, ... African Journal of Biomedical Research 22 (3), 347-352, 2019 | 4 | 2019 |
| The malaria concept in pregnancy and the mechanism of evading the immune system by the malaria parasite OA Durojaye, CC Ilo, D Okeowhor, RO Iyaji, O Onuorah, PO James, ... South Asian Journal of Parasitology 2 (1), 1-7, 2019 | 4 | 2019 |
| Review on structure-activity relationship (Sar) using antimalarial drug design as a case study S Cosmas, DE Ekpo, RO Asomadu, JO Assor, VI Nnamani, OA Durojaye Int. J. Sci. Eng. Res 9, 1743-1751, 2018 | 4 | 2018 |
Idris MukhtarOregon State University, OregonVerified email at mail.ustc.edu.cn
